These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 692910)
21. Immunoprophylaxis of transplantable methylcholanthrene-induced murine fibrosarcomas by immunization with embryo cells expressing endogenous murine leukemia virus antigens. Zbar B; Manohar V; Sugimoto T; Ashley MP; Kato Y; Rappaport P Cancer Res; 1981 Nov; 41(11 Pt 1):4499-507. PubMed ID: 6272979 [TBL] [Abstract][Full Text] [Related]
22. [Serological determination of specific surface antigens of cells from sarcomas induced by methylcholanthrene]. Lezhneva OM Tsitologiia; 1970 May; 12(5):666-74. PubMed ID: 4915907 [No Abstract] [Full Text] [Related]
23. Methylcholanthrene-induced mouse sarcomas express individually distinct major histocompatibility complex class I-associated peptides recognized by specific CD8+ T-cell lines. Kono K; Petersson M; Ciupitu AM; Wen T; Klein G; Kiessling R Cancer Res; 1995 Dec; 55(23):5648-55. PubMed ID: 7585649 [TBL] [Abstract][Full Text] [Related]
24. [Relationship between tumor antigens and histocompatibility antigens at the cell membrane]. Meyer G; Berebbi M; Oth D Bull Cancer; 1976; 63(1):111-21. PubMed ID: 791395 [TBL] [Abstract][Full Text] [Related]
25. Immunogenic properties of soluble cytosol fractions on Meth A sarcoma cells. DuBois GC; Appella E; Law LW; DeLeo AB; Old LJ Cancer Res; 1980 Nov; 40(11):4204-8. PubMed ID: 7471061 [TBL] [Abstract][Full Text] [Related]
26. Actinomycin-D-resistant in vitro mouse cell line derived from a methylcholanthrene-induced sarcoma: decrease of malignancy and antigenic characteristics. Belehradek J; Biedler JL; Thonier M; Barski G Int J Cancer; 1974 Dec; 14(6):779-88. PubMed ID: 4142788 [TBL] [Abstract][Full Text] [Related]
27. Bovine reaginic antibody. I. Rat mast cell degranulation by bovine allergic serum. Nielsen K; Holmes W; Wilkie B; Tizard I Int Arch Allergy Appl Immunol; 1976; 51(4):441-50. PubMed ID: 965104 [TBL] [Abstract][Full Text] [Related]
29. Thymocytolytic autoantibodies elicited by immunization of mice with chemically-induced sarcoma and leukemia cells. Merino F Acta Cient Venez; 1982; 33(5):402-5. PubMed ID: 6985343 [No Abstract] [Full Text] [Related]
30. Cell-mediated immune reactions as probes of sensitization to tumour-associated antigens of methylcholanthrene-induced mouse sarcomas. Bubeník J; Indrová M; Malkovský M; Símová J Arch Geschwulstforsch; 1981; 51(4):349-53. PubMed ID: 6172086 [TBL] [Abstract][Full Text] [Related]
31. Immunogenic strength of sarcomas induced by methylcholanthrene in millipore filter diffusion chambers. Parmiani G; Carbone G; Lembo R Cancer Res; 1973 Apr; 33(4):750-4. PubMed ID: 4696474 [No Abstract] [Full Text] [Related]
32. Effect of heterologous antimacrophage serum on growth of Rous virus-induced sarcoma in the allogeneic and syngeneic system. Holán V; Chutná J; Hasek M Neoplasma; 1977; 24(1):63-9. PubMed ID: 190550 [TBL] [Abstract][Full Text] [Related]
33. Activity of lymphocytes and antibodies derived from aging and adult rats bearing a MC-induced tumor in the syngeneic ADCC test. Nowak JJ; Ziółkowska M; Ryzewska A Neoplasma; 1987; 34(6):703-11. PubMed ID: 3431610 [TBL] [Abstract][Full Text] [Related]
34. Cross-reactive cellular and humoral immunity to carcinogen-induced chicken fibrosarcomas. II. Effect of prior immunization with transplantable tumors on primary tumor incidence. Edelman AS; Xue B; Galton JE; Sanchez P; Thorbecke GJ J Immunol; 1985 Sep; 135(3):2213-9. PubMed ID: 3926899 [TBL] [Abstract][Full Text] [Related]
35. [Antibodies against cells of methylcholanthrene sarcoma in the blood of intact mice]. Fedorovskaia MI; Vetrova EP; Umanskii IuA Biull Eksp Biol Med; 1973 Jul; 76(7):78-80. PubMed ID: 4774443 [No Abstract] [Full Text] [Related]
36. Anaphylactic antibodies in the mouse. Relationship to mast cell degranulation during in vivo anaphylactic reactions. Vaz EM; Silveira IH; Dodd VM; Monteiro MR; Vaz NM Int Arch Allergy Appl Immunol; 1970; 39(5-6):459-68. PubMed ID: 5492271 [No Abstract] [Full Text] [Related]
37. Studies of effects of recombinant human tumor necrosis factor on autochthonous tumor and transplanted normal tissue in mice. McIntosh JK; Mulé JJ; Travis WD; Rosenberg SA Cancer Res; 1990 Apr; 50(8):2463-9. PubMed ID: 2317830 [TBL] [Abstract][Full Text] [Related]
38. Immunotherapy of a carcinogen-induced murine sarcoma with soluble tumor-specific transplantation antigens. Kahan BD; Tanaka T; Pellis NR J Natl Cancer Inst; 1980 Nov; 65(5):1001-4. PubMed ID: 6159495 [TBL] [Abstract][Full Text] [Related]
39. Characterization of immunosuppressor cells in rats immunized with solubilized tumor-associated antigens prepared from a methylcholanthrene-induced fibrosarcoma. Minami A; Kasai M; Mizushima Y; Takeichi N; Hosokawa M; Kobayashi H Cancer Res; 1980 Jul; 40(7):2129-34. PubMed ID: 6446378 [TBL] [Abstract][Full Text] [Related]
40. Local degranulation and histamine release from a single rat mast cell by microelectrophoretic application of basic histamine releasers and antigen. Tasaka K; Yamasaki H Acta Derm Venereol Suppl (Stockh); 1973; 73():167-73. PubMed ID: 4131287 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]